Search results

Page results

• Evening dosing of blood pressure medication not better than morning dosing

  Taking blood pressure medication in the evening is no better than taking it in the morning, according to new research.

• Getting to Grips with Anxiety - Two-part online workshop

  This two-part workshop is specially created for teenagers seeking to understand their anxiety more deeply and discover practical, effective strategies to manage it.

• MENO.pause app launched to help clinicians manage patients’ menopause symptoms

  Doctors at UCLH and University College London (UCL) have developed a digital decision-making aid, MENO.pause, to help clinicians manage menopause symptoms in the best way for individual patients’ health conditions.

• RLHIM Integrated Children and Adolescent Service

  The Integrated Children and Adolescent Service is a long-established outpatient service of the Royal London Hospital for Integrated Medicine at UCLH.

• Good luck in the TCS London Marathon, UCLH Charity runners!

  The iconic run has returned to its regular time of the year, following two years’ disruption following the pandemic and will take place on Sunday 2 October 2022. We are lucky enough to have five people running for UCLH Charity. The money they raise will help us support patients, staff and research at UCLH.

• BBC documentary featuring UCLH clinicians highlights harms of ultra-processed food

  A BBC One documentary featuring clinicians at UCLH which airs this Thursday highlights the harm to the body and brain caused by ultra-processed food.

• NHS England consults on interim specification for new gender services

  NHS England has published a proposed interim specification for the new services for children and young people experiencing gender dysphoria.

• Covid-19 vaccine: Common stroke symptoms must be ‘urgently evaluated’

  UCLH and UCL neurologists have published the first clinical observations of patients who experienced an ischaemic stroke, the most common form of stroke, following an Oxford AstraZeneca vaccine.

• Next-generation treatment for multiple myeloma shows early promise

  Initial results from an early phase study testing the safety and efficacy of a new drug for multiple myeloma have shown a 100 per cent overall response rate in patients with recurrent disease who were given the clinically recommended dose of the investigational drug.

• New research collaboration to improve patient safety

  UCLH is to host to a new collaboration researching patient safety, after being awarded £3million in funding.